Publicaciones (69) Publicaciones de María Luisa Torres Durán

2024

  1. Proposal and Definition of an Intelligent Clinical Decision Support System Applied to the Prediction of Dyspnea after 12 Months of an Acute Episode of COVID-19

    Biomedicines, Vol. 12, Núm. 4

  2. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project

    Respiratory Research, Vol. 25, Núm. 1

  3. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry

    Archivos de Bronconeumologia

  4. Use of Intuitionistic Fuzzy Numbers to Prioritize Patients Suspected of Obstructive Sleep Apnea on the Cardiorespiratory Polygraphy Waiting List – A Novel Multi-Criteria Approach

    Lecture Notes in Educational Technology (Springer Science and Business Media Deutschland GmbH), pp. 289-298

2023

  1. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  2. Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries: EARCO international registry

    The European respiratory journal

  3. Comparative analysis according to alpha-1 Antitrypsin genotype in a cohort of patients with lung cancer in Northwest Spain

    Annual congress of the European-Respiratory-Society (ERS)

  4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry (Respiratory Research, (2022), 23, 1, (352), 10.1186/s12931-022-02275-4)

    Respiratory Research

  5. Design and Conceptual Proposal of an Intelligent Clinical Decision Support System for the Diagnosis of Suspicious Obstructive Sleep Apnea Patients from Health Profile

    International journal of environmental research and public health, Vol. 20, Núm. 4

  6. Design of an Intelligent Decision Support System Applied to the Diagnosis of Obstructive Sleep Apnea

    Diagnostics, Vol. 13, Núm. 11

  7. Identification of disease modifier genetic variants in PiZZ patients with alpha-1 antitrypsin deficiency

    Annual congress of the European-Respiratory-Society (ERS)

  8. Occupation as a risk factor of small cell lung cancer

    Scientific Reports, Vol. 13, Núm. 1

  9. Proceso asistencial para el diagnóstico y tratamiento del paciente con déficit de alfa-1 antitripsina (DAAT)

    Conselleria de Sanidade

  10. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

    International Journal of COPD, Vol. 18, pp. 1691-1700

  11. Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study

    Biomedicines, Vol. 11, Núm. 2

2022

  1. Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study

    BMC Cancer, Vol. 22, Núm. 1

  2. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

    Respiratory Research, Vol. 23, Núm. 1

  3. Demographic and clinical characteristics of patients with α1-antitrypsin deficiency genotypes PI*ZZ and PI*SZ in the Spanish registry of EARCO

    ERJ Open Research, Vol. 8, Núm. 3

  4. Fruits and Vegetables and Lung Cancer Risk in Never Smokers. A Multicentric and Pooled Case-Control Study

    Nutrition and Cancer, Vol. 74, Núm. 2, pp. 613-621

  5. Radon, Tobacco Exposure and Non-Small Cell Lung Cancer Risk Related to BER and NER Genetic Polymorphisms

    Archivos de Bronconeumologia, Vol. 58, Núm. 4, pp. 311-322